His lab is focusing on refining the alanine-scanning assay to a few key residues that may correctly distinguish among fibrils from neurodegenerative tauopathies. He envisions making use of this streamlined assay for postmortem neuropathological diagnosis, and possibly for blood screening of tauopathies.They demonstrated this marriage with each path